Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant

NCT00388999 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
DRUG: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)

Sponsor

Enzon Pharmaceuticals, Inc.